Literature DB >> 22065092

Environment and lupus-related diseases.

G Zandman-Goddard1, M Solomon, Z Rosman, E Peeva, Y Shoenfeld.   

Abstract

Clinical manifestations of lupus are encountered in a variety of disease entities, including isolated cutaneous lupus, undifferentiated connective tissue disease, mixed connective tissue disease, drug-induced lupus, overlap syndrome, and systemic lupus erythematosus (SLE). While each entity has been recognized as a specific disease with its own diverse clinical and serological pattern, one could argue that many findings are common. Could it be that all of these entities actually represent a spectrum of one disease? Could it be that rather than the genetic predisposition and hence controlled factors that govern this spectrum of diseases, that environmental factors associated with SLE could also play a role in the different entities of this spectrum? The traditional environmental triggers in SLE include sunlight and ultraviolet (UV) light, infections, smoking, and medications including biologics such as tumor necrosis factor alpha (TNF-a) blockers. In this review, we update and further substantiate these traditional factors in the various lupus-related syndromes. We will also discuss the association with vaccine exposure, industrial estrogens, and other factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065092     DOI: 10.1177/0961203311426568

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  34 in total

1.  Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses' Health Study Cohorts.

Authors:  Medha Barbhaiya; Bing Lu; Jeffrey A Sparks; Susan Malspeis; Shun-Chiao Chang; Elizabeth W Karlson; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

Review 2.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

3.  Impact of the polymorphism in vitamin D receptor gene BsmI and the risk of systemic lupus erythematosus: an updated meta-analysis.

Authors:  Weiping Hu; Guodong Niu; Yong Lin; Xiaoqing Chen; Ling Lin
Journal:  Clin Rheumatol       Date:  2015-12-28       Impact factor: 2.980

Review 4.  Infections and systemic lupus erythematosus.

Authors:  S Esposito; S Bosis; M Semino; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

5.  Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice.

Authors:  B M Johnson; M-C Gaudreau; M M Al-Gadban; R Gudi; C Vasu
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

Review 6.  Autoantibodies and SLE: the threshold for disease.

Authors:  Nancy J Olsen; David R Karp
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

7.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

Review 8.  Photosensitivity in cutaneous lupus erythematosus.

Authors:  Andrew Kim; Benjamin F Chong
Journal:  Photodermatol Photoimmunol Photomed       Date:  2013-02       Impact factor: 3.135

Review 9.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

10.  IL10 restrains autoreactive B cells in transgenic mice expressing inactive RAG1.

Authors:  Victoria L Palmer; Alexandra N Worth; Robyn L Scott; Greg A Perry; Mei Yan; Quan-Zhen Li; Patrick C Swanson
Journal:  Cell Immunol       Date:  2018-06-13       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.